This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway
Jing Wang, Hong-Min Guo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeurological Disease Mechanisms and Treatments · Traditional Chinese Medicine Analysis
Exp Ther Med 17:4409–4416, 2019; DOI: 10.3892/etm.2019.7495
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that flow cytometric assay (FCM) data featured in Fig. 2B on p. 4412 were strikingly similar to FCM data which were ultimately published in other papers in different journals that were written by different authors at different research institutes, one of which was submitted to the journal Biomedicine & Pharmacotherapy and has since been retracted.
Owing to the fact that the contentious data in the above article were found to be strikingly similar to data that had already been submitted for publication elsewhere in other papers in different journals, the Editor of Experimental and Therapeutic Medicine has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused.